Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZG9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,467.00 to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body injectable medication. This firm fixed-price delivery order, issued on January 6, 2026, with an ultimate completion date of January 28, 2026, represents a non-competitive award under an existing contract vehicle. The product will be delivered to the company's pharmaceutical distribution facility in Conshohocken, Pennsylvania. SKYRIZI (risankizumab) is a biologic immunosuppressant medication primarily used in the treatment of dermatological and gastrointestinal inflammatory conditions, making it consistent with the Defense Logistics Agency Medical Supply Chain's mission to support military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen operates as a subsidiary of parent company Cencora, Inc., and serves as a critical pharmaceutical distributor to federal government agencies including the Defense Health Agency and U.S. Coast Guard. The company's contract portfolio demonstrates extensive experience fulfilling federal procurement requirements for specialty medications, brand-name and generic pharmaceuticals, and medical supplies across multiple therapeutic domains, establishing it as a qualified vendor for supporting military healthcare programs on a global scale.
Quick answers
Who was awarded contract SPE2DR26F0ZG9?
SPE2DR26F0ZG9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F0ZG9 worth?
The government has obligated $12,467 on SPE2DR26F0ZG9.
Is contract SPE2DR26F0ZG9 an order under another contract?
Yes. SPE2DR26F0ZG9 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZG9 competed?
The extent of competition for SPE2DR26F0ZG9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award